THOMPSON JOHN CRAIG
Insider CIK 1509643 · ANTH President & COO, Director · TSRX Chief Commercial Officer · TTPH Chief Operating Officer · ESPR Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ESPR Esperion Therapeutics, Inc | D To issuer deriv | 2026-07-13 | 2026-07-13 | 40,000 | — | $0 | 0 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | D To issuer | 2026-07-13 | 2026-07-13 | 79,873 | — | $0 | 0 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | A Award | 2026-05-28 | 2026-06-01 | 79,873 | — | $0 | 79,873 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | A Award deriv | 2025-07-01 | 2025-07-02 | 40,000 | — | $0 | 40,000 | SEC↗ |
| ANTH Anthera Pharmaceuticals In | A Award deriv | 2018-01-05 | 2018-01-09 | 1,847,074 | — | $0 | 1,847,074 | SEC↗ |
| ANTH Anthera Pharmaceuticals In | P Buy | 2017-09-20 | 2017-09-20 | 8,550 | $1.32 | $11.3K | 19,848 | SEC↗ |
| ANTH Anthera Pharmaceuticals In | M Exercise | 2017-09-07 | 2017-09-07 | 10,400 | $1.43 | $14.9K | 17,590 | SEC↗ |
| ANTH Anthera Pharmaceuticals In | P Buy | 2017-09-07 | 2017-09-07 | 10,400 | $1.43 | $14.9K | 11,298 | SEC↗ |
| ANTH Anthera Pharmaceuticals In | A Award deriv | 2017-05-20 | 2017-05-22 | 81,250 | — | $0 | 81,250 | SEC↗ |
| ANTH Anthera Pharmaceuticals In | A Award deriv | 2017-03-03 | 2017-03-03 | 100,000 | — | $0 | 100,000 | SEC↗ |
| ANTH Anthera Pharmaceuticals In | A Award deriv | 2016-12-06 | 2017-03-03 | 200,000 | — | $0 | 200,000 | SEC↗ |
| ANTH Anthera Pharmaceuticals In | A Award deriv | 2016-12-06 | 2016-12-06 | 300,000 | — | $0 | 300,000 | SEC↗ |
| ANTH Anthera Pharmaceuticals In | A Award deriv | 2016-06-09 | 2016-06-13 | 170,000 | — | $0 | 170,000 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | M Exercise deriv | 2015-09-08 | 2015-09-10 | 10,000 | — | $0 | 157,501 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | M Exercise | 2015-09-08 | 2015-09-10 | 10,000 | $14.45 | $144.5K | 10,343 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | S Sale | 2015-09-08 | 2015-09-10 | 10,000 | $44.08 | $440.8K | 343 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | M Exercise deriv | 2015-08-05 | 2015-08-07 | 10,000 | — | $0 | 167,501 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | M Exercise | 2015-08-05 | 2015-08-07 | 10,000 | $14.45 | $144.5K | 10,343 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | S Sale | 2015-08-05 | 2015-08-07 | 10,000 | $46.31 | $463.1K | 343 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | M Exercise deriv | 2015-07-06 | 2015-07-08 | 10,000 | — | $0 | 177,501 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | M Exercise | 2015-07-06 | 2015-07-08 | 10,000 | $14.45 | $144.5K | 10,343 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | S Sale | 2015-07-06 | 2015-07-08 | 10,000 | $47.91 | $479.1K | 343 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | M Exercise deriv | 2015-06-15 | 2015-06-16 | 10,000 | — | $0 | 187,501 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | M Exercise | 2015-06-15 | 2015-06-16 | 10,000 | $14.45 | $144.5K | 10,343 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | S Sale | 2015-06-15 | 2015-06-16 | 10,000 | $41.51 | $415.1K | 343 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | M Exercise deriv | 2015-06-08 | 2015-06-10 | 22,499 | — | $0 | 197,501 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | S Sale | 2015-06-08 | 2015-06-10 | 11,862 | $43.50 | $516.0K | 10,980 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | S Sale | 2015-06-08 | 2015-06-10 | 10,637 | $43.00 | $457.4K | 343 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | M Exercise | 2015-06-08 | 2015-06-10 | 22,499 | $14.45 | $325.1K | 22,842 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | M Exercise deriv | 2015-05-15 | 2015-05-19 | 30,000 | — | $0 | 220,000 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | M Exercise | 2015-05-15 | 2015-05-19 | 30,000 | $14.45 | $433.5K | 30,343 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | S Sale | 2015-05-15 | 2015-05-19 | 30,000 | $39.63 | $1.19M | 343 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | A Award deriv | 2015-01-07 | 2015-01-09 | 100,000 | — | $0 | 100,000 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | A Award deriv | 2014-02-03 | 2014-02-05 | 250,000 | — | $0 | 250,000 | SEC↗ |
| TSRX Trius Therapeutics Inc | D To issuer deriv | 2013-09-11 | 2013-09-13 | 125,000 | $7.37 | $921.3K | 0 | SEC↗ |
| TSRX Trius Therapeutics Inc | D To issuer deriv | 2013-09-11 | 2013-09-13 | 150,000 | $9.20 | $1.38M | 0 | SEC↗ |
| TSRX Trius Therapeutics Inc | D To issuer deriv | 2013-09-11 | 2013-09-13 | 90,000 | $8.70 | $783.0K | 0 | SEC↗ |
| TSRX Trius Therapeutics Inc | D To issuer | 2013-09-11 | 2013-09-13 | 2,455 | — | $0 | 0 | SEC↗ |
| TSRX Trius Therapeutics Inc | A Award deriv | 2013-03-07 | 2013-03-11 | 125,000 | — | $0 | 125,000 | SEC↗ |
| TSRX Trius Therapeutics Inc | A Award deriv | 2012-03-08 | 2012-03-12 | 90,000 | — | $0 | 90,000 | SEC↗ |